| __timestamp | Eli Lilly and Company | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6620800000 | 2917513 |
| Thursday, January 1, 2015 | 6533000000 | 7878291 |
| Friday, January 1, 2016 | 6452000000 | 8366794 |
| Sunday, January 1, 2017 | 6588100000 | 6610381 |
| Monday, January 1, 2018 | 5975100000 | 6556000 |
| Tuesday, January 1, 2019 | 6213800000 | 6930000 |
| Wednesday, January 1, 2020 | 6121200000 | 8758000 |
| Friday, January 1, 2021 | 6431600000 | 10806000 |
| Saturday, January 1, 2022 | 6440400000 | 9844000 |
| Sunday, January 1, 2023 | 6941200000 | 13481000 |
| Monday, January 1, 2024 | 8593800000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Eli Lilly and Company, a giant in the industry, and Soleno Therapeutics, Inc., a smaller player, offer a fascinating contrast in SG&A cost management from 2014 to 2023.
Eli Lilly's SG&A expenses have shown a steady trend, averaging around $6.4 billion annually. Despite fluctuations, their expenses peaked in 2023, reflecting a strategic investment in growth. In contrast, Soleno Therapeutics, with an average SG&A expense of approximately $8.2 million, has seen a significant increase of over 360% from 2014 to 2023. This rise indicates a potential expansion phase or increased operational costs.
Understanding these trends provides insights into how companies of different scales manage their operational costs, impacting their financial health and market strategies.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Axsome Therapeutics, Inc.
Comparing SG&A Expenses: Eli Lilly and Company vs Merus N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared